You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

Drug Price Trends for DICLOFENAC SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DICLOFENAC SODIUM

Average Pharmacy Cost for DICLOFENAC SODIUM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
DICLOFENAC SODIUM 1% GEL 00536-1294-97 0.09175 GM 2025-03-19
DICLOFENAC SODIUM 1% GEL 43598-0977-10 0.09175 GM 2025-03-19
DICLOFENAC SODIUM 1% GEL 45802-0953-01 0.09175 GM 2025-03-19
DICLOFENAC SODIUM 1% GEL 21922-0044-09 0.09175 GM 2025-03-19
DICLOFENAC SODIUM 3% GEL 71085-0003-00 0.36327 GM 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Diclofenac Sodium Market Analysis and Price Projections

Market Overview

Diclofenac sodium, a widely used non-steroidal anti-inflammatory drug (NSAID), is experiencing significant growth in the global pharmaceutical market. Here is a comprehensive analysis of the market, including its size, growth projections, key drivers, and challenges.

Market Size and Forecast

The global diclofenac sodium market is substantial and growing steadily. As of 2024, the market size was valued at approximately $2.5 billion and is projected to reach $3.7 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.5% from 2024 to 2031[2].

Another projection indicates that the market could grow from $4.2 billion in 2023 to $6.4 billion by 2033, with a CAGR of 4.3% during this period[3].

Key Drivers

Several factors are driving the growth of the diclofenac sodium market:

Increasing Prevalence of Chronic Pain and Arthritis

The rising incidence of chronic pain and arthritis globally is a major driver. Conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis are becoming more common, especially among the geriatric population[3].

Growing Geriatric Population

The increasing number of elderly individuals, who are more prone to inflammation-related problems, is fueling the demand for diclofenac sodium. This demographic shift is particularly significant in regions like North America and Asia-Pacific[5].

Sports-Related Injuries

Diclofenac topical treatments are extensively marketed to treat sports-related injuries and conditions such as knee osteoarthritis. This has created a significant demand, especially in regions with high sports activity[2].

Improved Formulations and Delivery Methods

Recent developments in the formulation and delivery methods of diclofenac, such as transdermal patches, are reducing systemic adverse effects and improving patient outcomes. These innovations are supporting market growth by offering safer and more effective treatment options[4].

Market Segmentation

By Type

The market is segmented by type, with tablets leading the market share. Other forms include injections and transdermal patches. Tablets account for a significant portion of the market, with a 55.5% market share[3].

By Application

Diclofenac sodium is used to treat a variety of conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dysmenorrhea, and sports-related injuries. Osteoarthritis indications account for 37.5% of diclofenac usage[3].

By Geography

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominates the market due to its robust medical infrastructure and high healthcare expenditure. However, Asia-Pacific is expected to offer lucrative growth opportunities due to local government support for medical developments and a growing senior population[2][5].

Competitive Landscape

The diclofenac sodium market is competitive, with several key players:

  • Hunan Warrant Pharmaceutical Co., Ltd.
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
  • Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd.
  • Zhejiang Deyer Pharmaceutical Co., Ltd.
  • Nanjing Yiheng Pharmaceutical Co., Ltd.
  • Beijing Novartis Pharma Co., Ltd.
  • Novartis Pharma GmbH
  • Lannett Company, Inc.
  • Elam Pharma[1]

Other notable players in the diclofenac patches market include Pfizer Inc., Cadila Healthcare, GlaxoSmithKline Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co., Inc., and Teikoku Seiyaku Co., Ltd.[4].

Challenges and Restraints

Despite the growth, the market faces several challenges:

Side Effects

Diclofenac sodium is associated with potential side effects such as cardiovascular and gastrointestinal issues, which can restrain its usage and market expansion[3].

Regulatory and Patent Issues

Drug patent expirations and regulatory challenges can also hamper industry growth. The need for new anti-inflammatory treatments with fewer side effects and improved efficacy is a significant challenge[2].

Acceptance of New Formulations

The acceptance of new formulations like transdermal patches is lower compared to traditional tablets or injections due to lack of awareness and resistance to new concepts among medical professionals and patients[4].

Regional Analysis

North America

North America holds a dominant position in the diclofenac sodium market due to its robust medical infrastructure, high healthcare expenditure, and extensive awareness of diclofenac usage. The U.S. and Canada are key markets in this region[2][5].

Asia-Pacific

Asia-Pacific is expected to offer significant growth opportunities due to strong medical advertisements, local government support for medical developments, and a growing senior population. Countries like India and China are driving this growth[2][5].

Europe

Europe is another significant market, with countries like Germany, the U.K., and France contributing to the regional growth[2].

Price Projections

The price of diclofenac sodium is influenced by various factors including production costs, regulatory environments, and market demand.

  • Generic Competition: The expiration of patents for diclofenac sodium has led to increased generic competition, which can drive prices down.
  • Innovative Formulations: New formulations like transdermal patches may command higher prices due to their improved safety profiles and efficacy.
  • Regional Variations: Prices can vary significantly across different regions due to differences in healthcare policies, regulatory frameworks, and market dynamics.

Given the projected market growth and increasing demand, it is likely that the prices of diclofenac sodium will remain stable or see a moderate increase over the forecast period, especially for innovative formulations.

Key Takeaways

  • The global diclofenac sodium market is projected to grow significantly, driven by increasing chronic pain and arthritis cases, a growing geriatric population, and improved formulations.
  • North America dominates the market, but Asia-Pacific is expected to offer lucrative growth opportunities.
  • Key players are focusing on innovative delivery methods to reduce side effects and improve patient outcomes.
  • Despite growth, the market faces challenges from side effects, regulatory issues, and resistance to new formulations.

FAQs

1. What is the current market size of the global diclofenac sodium market?

The global diclofenac sodium market was valued at approximately $2.5 billion in 2024 and is projected to reach $3.7 billion by 2031[2].

2. What are the key drivers of the diclofenac sodium market?

Key drivers include the increasing prevalence of chronic pain and arthritis, a growing geriatric population, and improved formulations and delivery methods[2][3].

3. Which region dominates the diclofenac sodium market?

North America currently dominates the market due to its robust medical infrastructure and high healthcare expenditure[2][5].

4. What are the potential side effects of diclofenac sodium?

Diclofenac sodium is associated with potential side effects such as cardiovascular and gastrointestinal issues[3].

5. How is the acceptance of new formulations like transdermal patches?

The acceptance of new formulations like transdermal patches is lower compared to traditional tablets or injections due to lack of awareness and resistance to new concepts among medical professionals and patients[4].

Sources

  1. Valuates Reports: Diclofenac Sodium Sustained-release Tablets - Market.
  2. Verified Market Research: Diclofenac Sodium Market Size, Share, Trends & Forecast.
  3. News Market: Diclofenac Market Growth Accelerates Amid Increased Demand.
  4. Coherent Market Insights: Diclofenac Patches Market Size, Trends And Forecast To 2028.
  5. IndustryARC: Diclofenac Market Size Report, 2022-2027.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.